NG Industries Ltd.
Snapshot View

View in App

Prices View details >>

77.75 -2.35 ▼-2.9%

09 February 2023, 03:31:00 PM
Volume: 4,060

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Hospital & Healthcare Services Compare with Industry peers
Website http://www.ngind.com
Market Cap 24.96 Cr.
Enterprise Value(EV) 25.49 Cr. 2022-09
Financial Indicators
Earnings per share (EPS) 23.43 Trailing Twelve Months Ending 2022-09
Price-Earning Ratio (PE) 3.18 Trailing Twelve Months Ending 2022-09
Industry PE 46.98 Trailing Twelve Months Ending 2022-09
Book Value / Share 78.03 Trailing Twelve Months Ending 2022-09
Price to Book Value 0.95 Calculated using Price: 74.50
Dividend Yield 4.70 Period Ending 2022-03
No. of Shares Subscribed 0.34 Cr. 3,350,500 Shares
FaceValue 10
Company Profile
The company's principal activity is to provide healthcare and medical services. The company facilitates through the treatments and services like, imaging, cardiology, endoscopy, neurology, pathology, orthopaedics, infertility, surgery, operation theatres, indoor ward and surgery.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
-2.93%
1 Week
-0.45%
1 Month
-3.89%
3 Month
-6.72%
6 Month
+9.51%
1 Year
+10.60%
2 Year
+90.10%
5 Year
-1.83%
10 Year
+6.58%

Ratios View Details >>

9 years 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) 10.66 9.97 10.63 9.81 7.18 9.86 14.44 5.04 13.41
Return on Capital Employed (%) 13.62 12.93 15.93 14.33 11.81 14.94 17.80 6.57 17.19
Return on Assets (%) 8.03 8.32 9.10 8.17 6.35 9.59 12.71 4.38 11.96

Balance Sheet View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09* Rs. Cr.
Shh. Funds 14 14 14 14 12 11 9 15 24 26
Non Curr. Liab. 0 0 0 0 -2 -2 -2 -1 2
Curr. Liab. 3 3 3 3 2 2 5 2 2 3
Minority Int.
Equity & Liab. 18 17 17 18 12 11 12 16 27 29
Non Curr. Assets 15 15 15 15 10 9 9 14 22 23
Curr. Assets 3 2 2 3 2 3 2 3 5 6
Misc. Exp. not W/O
Total Assets 18 17 17 18 12 11 12 16 27 29

Profit Loss View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09 Rs. Cr. TTM
Net Sales 14 15 17 17 17 18 19 12 18 20
Other Income 1 1 0 0 0 0 0 0 2 7
Total Income 14 15 17 17 18 18 19 12 20 27
Total Expenditure -11 -12 -14 -15 -15 -15 -16 -11 -16 -17
PBIDT 3 3 3 3 2 2 3 1 4 10
Interest 0 0 0 0 0 0 0 0 0 0
Depreciation -1 -1 -1 -1 -1 -1 -1 0 -1 -1
Taxation -1 -1 -1 -1 -1 -1 -1 0 -1 -1
Exceptional Items
PAT 2 1 2 1 1 1 1 1 3 8
Adjusted EPS 5 4 5 4 3 3 4 2 8 23

Cash Flow View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. 2 2 2 2 2 2 4 3 1 -2
Cash Fr. Inv. -4 2 -1 -1 -1 -2 -1 -3 2 1
Cash Fr. Finan. 2 -4 -2 -1 -1 -2 -2 0 -3 0
Net Change 0 0 -1 0 0 -1 1 0 1 0
Cash & Cash Eqvt 2 2 1 1 1 0 1 1 2 1

Shareholding Pattern View Details >>

9 Qtrs 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%)
Promoter 74.50 74.50 74.50 74.50 74.50 74.50 74.50 74.50 74.50
Public 25.50 25.50 25.50 25.50 25.50 25.50 25.50 25.50 25.50
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details >>

Fri, 03 Feb 2023
Board Meeting Intimation for Consideration And Approval Of The Un-Audited Standalone Financial Results Of The Company For The Quarter And Nine Months Ended 31St December 2022 For The Financial Year 2022-23.
N.G.INDUSTRIES LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2023 inter alia to consider and approve the Un-audited Standalone Financial Results of the Company for the Quarter and Nine Months ended 31st December 2022 for the Financial Year 2022-23.
Sat, 07 Jan 2023
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
Fri, 30 Dec 2022
Closure of Trading Window
Closure of Trading Window

Technical Scans View Details >>

Wed, 08 Feb 2023
High Delivery Percentage High Delivery Percentage
Opening at High Opening at High
Opening at High for 3 days Opening at High for 3 days
High Increase in 2 Years High Increase in 2 Years
Tue, 07 Feb 2023
Opening at High Opening at High

Related Stocks View Details >>

  • SALES
Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 243,148.61 1,006.80 -0.6%
Cipla Ltd. 83,886.47 1,021.50 -1.7%
Dr. Reddy's Laboratories Ltd. 74,707.50 4,487.50 0.0%
Divi's Laboratories Ltd. 74,340.49 2,823.15 +0.9%
Apollo Hospitals Enterprise Ltd. 63,077.61 4,389.30 0.0%
Torrent Pharmaceuticals Ltd. 52,675.65 1,540.20 -1.1%
Zydus Lifesciences Ltd. 47,993.66 474.40 +0.1%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-12 57.66 1,006.80 -0.6%
Cipla Ltd. Consolidated 2022-12 31.80 1,021.50 -1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 20.50 4,487.50 0.0%
Divi's Laboratories Ltd. Consolidated 2022-12 31.01 2,823.15 +0.9%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-09 75.13 4,389.30 0.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 63.19 1,540.20 -1.1%
Zydus Lifesciences Ltd. Consolidated 2022-12 23.29 474.40 +0.1%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-12 4.39 1,006.80 -0.6%
Cipla Ltd. Consolidated 2022-12 3.70 1,021.50 -1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 3.39 4,487.50 0.0%
Divi's Laboratories Ltd. Consolidated 2022-12 5.98 2,823.15 +0.9%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-09 10.54 4,389.30 0.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 8.24 1,540.20 -1.1%
Zydus Lifesciences Ltd. Consolidated 2022-12 2.78 474.40 +0.1%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.03 1,006.80 -0.6%
Cipla Ltd. Consolidated 2022-03 0.04 1,021.50 -1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,487.50 0.0%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 2,823.15 +0.9%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,389.30 0.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,540.20 -1.1%
Zydus Lifesciences Ltd. Consolidated 2022-03 0.25 474.40 +0.1%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 1,006.80 -0.6%
Cipla Ltd. Consolidated 2022-03 13.10 1,021.50 -1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,487.50 0.0%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 2,823.15 +0.9%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,389.30 0.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,540.20 -1.1%
Zydus Lifesciences Ltd. Consolidated 2022-03 15.51 474.40 +0.1%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 1,006.80 -0.6%
Cipla Ltd. Consolidated 2022-03 13.10 1,021.50 -1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,487.50 0.0%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 2,823.15 +0.9%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,389.30 0.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,540.20 -1.1%
Zydus Lifesciences Ltd. Consolidated 2022-03 15.51 474.40 +0.1%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 1,006.80 -0.6%
Cipla Ltd. Consolidated 2022-03 21,763.34 1,021.50 -1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,487.50 0.0%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 2,823.15 +0.9%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,389.30 0.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,540.20 -1.1%
Zydus Lifesciences Ltd. Consolidated 2022-03 15,265.20 474.40 +0.1%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 1,006.80 -0.6%
Cipla Ltd. Consolidated 2022-03 2,559.47 1,021.50 -1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,112.20 4,487.50 0.0%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 2,823.15 +0.9%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,389.30 0.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,540.20 -1.1%
Zydus Lifesciences Ltd. Consolidated 2022-03 2,326.40 474.40 +0.1%

FAQ's On NG Industries Ltd.

What is NG Industries share price?
Can I buy NG Industries shares now?
What is the Dividend Yield of NG Industries?
What is the Market Cap of NG Industries?
What are the key metrics to analyse NG Industries?
What is the 52 Week High and Low of NG Industries?
What is the trend of NG Industries share price?